|
|||||
PalivizumabPalivizumab Article SummaryPalivizumab (brand Name Synagis) Is A Monoclonal Antibody Produced By Recombinant Dna Technology. It Is Used In The Prevention Of Respiratory Syncytial Virus (rsv) Infections. It Is Recommended For Certain Infants That Are High-risk (because Of Prematurity Or Other Medical Problems), See Below. palivizumab Is A Humanized Monoclonal Antibody (igg) Directed Against An Epitope In The A Antigenic Site Of The F Protein Of The Respiratory Syncytial Virus (rsv). In Two Phase Iii Clinical Trials In The ... Read the Full Palivizumab ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Palivizumab Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to PalivizumabInjection 100mg, 100mg/ml, 50mg, 50mg/ml Vial 100mg/vial, 50mg/vial Related Drug Page(s): Related Search Results for PalivizumabWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Palivizumab Text Link HTML Code: Related: Palivizumab locate, list questions questions Palivizumab, Palivizumab tablet rx pills headline physician, Palivizumab pill, training Palivizumab, warnings withdrawal physician Palivizumab, Palivizumab technical, dosage pill Palivizumab, Palivizumab drug picture, pdr identification Palivizumab. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Palivizumab.asp Last Updated June 27 2005 |
|||||